THE DIAGNOSTIC ODYSSEY

Why Target Rare
Disease Patients?


Rare disease patients typically wait 5-8 years to get an accurate diagnosis. This search for answers is known as diagnostic odyssey. During a diagnostic odyssey, rare disease patients will see up to 10 different providers, half of which are specialists, be misdiagnosed three times and inappropriately care for at least twice, while frequently being tagged as psychosomatic or drug seekers. Patients also face irreparable harm to their bodies as well as running the risk of their therapeutic window closing.




Healthcare Provider White Paper

Validating model compliance authored by leading
law firm in healthcare sector, available post NDA


Contact Us to Learn More


Fair Market Valuation Analysis

Authored by leading a FMV firm in the Healthcare sector, validating cost and revenue streams of model, available post-NDA


Contact Us to Learn More

 
WE BELIEVE WE CAN DO BETTER

If you could address this gap in care alone, we're sure you would have already. Together, we can do better – we can stop the odyssey. Our model accelerates the accurate diagnosis of rare diseases for the benefit of the patient and the provider.


SCHEDULE A CALL
HOW IT WORKS

Unmatched Experience

Our team's combined 40+ years in the rare disease marketplace and personal experience with the rare disease diagnostic odyssey led us to believe that there had to be a better way. We knew the data to accelerate rare disease diagnoses and target patients existed in the electronic health records. We just had to figure out how to access it while protecting patient privacy and maintaining legal compliance. Rare Disease Data Trust is the solution.




Data Integration

Our team integrates your electronic health record data with our secure cloud-based rare disease analytics platform where structured and unstructured data is prepared for rare disease patient searches.




Patient Search

We apply our proprietary rare disease search data models to identify probable rare disease patients. You are notified about these patients via secure portal. We provide a clinical dossier to inform treating physicians about the rare disease, all approved and emerging therapies, and the accepted confirmatory diagnostic protocol.




Diagnostic Triage

Now, you do what you do best. Using the clinical information we provided in the dossier, you decide who is best suited to reach out to the probable patient, schedule diagnostic testing, conduct the testing and communicate results to the patient. The dossier informs the physician about resources available to assist in care planning. The provider and patient can then independently decide on the best path forward.




Generate Revenue

In establishing a rare disease service line, sharing data for patient searches, accelerating accurate diagnosis, and facilitating evidence-based care for these patients, you create significant value. Rare Disease Data Trust recognizes this value in the compliant revenue stream we create for provider partners.


Slide Let's end the diagnostic odyssey. check_circle Accelerated and accurate diagnosis for rare disease patients check_circle Efficient process and solutions for providers check_circle Substantive new service line that's high revenue/high margin check_circle Enhanced reputation as a patient-centered, solutions-oriented health system check_circle Maintain compliance with HIPAA, Stark, AKS and other relevant regulations Schedule a call Henri Termeer, one of the greatest and most successful visionaries in biotech. Henri Termeer believed you could change the world and he did so for many people suffering from devastating diseases. He often said that if we can create medicines to help people, it is our responsibility to do so no matter how complex or difficult the task. Under his leadership, he fulfilled this mission and in doing so grew Genzyme from a modest entrepreneurial venture to one of the world's leading biotechnology companies and a pioneer of some of the first treatments for rare genetic diseases. Henri passed in May 2017.